PharmExec Blog
Follow Us
RSS
Bookstore
Category Archives: News
Understanding Serious Adverse Events Takes Serious Cooperation
What if the technology is at hand to prevent adverse reactions to medicines before they start?
The International Serious Adverse Events Consortium (iSAEC) came together in 2007 to research the cause of certain drug-induced serious adverse reactions, posing the question, “What if the identification of risk for adverse events were not a random development, but instead [...]
Financial Woes Affect Cancer Patients’ Treatment Decisions
A recent survey conducted by MDLinx reveals that 95 percent of the nation’s oncologists report a rise in their patients’ concerns over treatment costs in the past six months.
Of the 106 US oncologists surveyed in a MDLinx survey last month, 84 percent said they had invested more time and effort into the financial planning of [...]
Pfizer Ends Sutent Trial
Successful cancer drug Sutent may not be effective in prolonging life for patients with castration-resistant prostate cancer.
This week, Pfizer announced that it has ended a Phase III trial of cancer drug Sutent. The drug, which was being tested as a treatment for patients with prostate cancer, has already been approved as a treatment for kidney [...]
New FDA Campaign Targets Detailing, Trade Shows
In addition to sending out more warning letters and stepping up enforcement activity, the Food and Drug Administration wants health professionals to do more to police drug marketing and advertising. The agency’s “Bad Ad” program urges doctors and other health professionals to report any false or misleading ads or inappropriate marketing pitches. Depending on one’s [...]
Also posted in FDA, Regulatory Tagged Advertising, DDMAC, Detailing, FDA, Margaret Hamburg, Marketing, Professional Marketing Leave a comment
Merck Gets to the Heart of the Matter